Fap-IN-2

Fap-IN-2 is a small molecule inhibitor specifically designed to target fibroblast activation protein (FAP), a serine protease prominently expressed in activated fibroblasts within the tumor microenvironment and in fibrotic tissues. As a potent and selective FAP inhibitor, Fap-IN-2 serves as a valuable research tool for dissecting the biological functions of FAP in processes such as tissue remodeling, cancer progression, and fibrosis. Its well-characterized mechanism of action and high specificity make it an essential compound for studies aiming to elucidate FAP-related signaling pathways and cellular dynamics in both physiological and pathological contexts.

Cancer biology research: In the context of oncology, FAP plays a crucial role in the remodeling of the extracellular matrix and the promotion of tumor growth and metastasis. Fap-IN-2 enables researchers to selectively inhibit FAP activity in in vitro and in vivo models, thereby facilitating investigations into the contribution of cancer-associated fibroblasts to tumorigenesis. By modulating FAP-dependent pathways, the inhibitor helps clarify the interplay between stromal components and malignant cells, supporting the identification of novel targets for anti-cancer strategies.

Fibrosis modeling: FAP is markedly upregulated in fibrotic lesions across various organs, including the liver, lungs, and kidneys. Fap-IN-2 is widely utilized in preclinical studies to probe the molecular mechanisms underlying tissue fibrosis. Its application allows for the assessment of FAP's role in fibroblast activation, extracellular matrix deposition, and fibrogenic signaling cascades. This targeted approach provides critical insights into the pathogenesis of fibrotic diseases and aids in the validation of FAP as a potential biomarker or intervention point in anti-fibrotic research.

Enzyme activity assays: The compound is frequently employed in biochemical assays aimed at quantifying FAP enzymatic activity and evaluating the selectivity of novel inhibitors. Fap-IN-2 serves as a benchmark inhibitor in fluorometric, colorimetric, or mass spectrometry-based assays, enabling the characterization of FAP substrate specificity, inhibitor potency, and kinetic parameters. Its use in these assays accelerates the development of next-generation FAP-targeted compounds and supports high-throughput screening efforts in drug discovery.

Cell signaling studies: By blocking FAP-mediated proteolytic processing, Fap-IN-2 provides a means to investigate downstream signaling events and cellular responses regulated by FAP. Researchers utilize the inhibitor to delineate pathways involved in cell migration, invasion, and immune modulation within the stromal microenvironment. Such studies contribute to a deeper understanding of how FAP orchestrates complex cellular interactions and influences tissue homeostasis or disease progression.

Probe development and validation: Fap-IN-2 is instrumental in the design and validation of FAP-targeted molecular probes, including imaging agents and affinity reagents. Its defined inhibitory profile allows for the assessment of probe specificity and functionality in complex biological samples. By serving as a reference compound during probe optimization, it ensures the reliability and interpretability of results in both basic research and translational applications focused on FAP expression and activity.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)